{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:45:11Z","timestamp":1769741111513,"version":"3.49.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"crossref","award":["2019312009"],"award-info":[{"award-number":["2019312009"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Most cases of primary microvascular angina pectoris (PMVA) are diagnosed clinically, but the etiology and pathological mechanisms are unknown. The effect of routine clinical medications is minimal, and PMVA can progress to serious cardiovascular events. To improve the diagnosis and effective treatment of this disease, this study was designed to diagnose PMVA via cardiovascular magnetic resonance (CMR) and the coronary angiography thrombolysis in myocardial infarction (TIMI) blood flow grade, as well as to analyze vascular endothelial function to elucidate the pathogenesis of PMVA and compare the effects of routine clinical medications.<\/jats:p>\n            <jats:p>The present randomized controlled trial including a parallel control group will be conducted on 63 PMVA patients in our cardiovascular department. The patients will be selected and randomly divided into the control, diltiazem, and nicorandil groups. The control group will be administered routine drug treatments (aspirin, atorvastatin, betaloc ZOK, perindopril, and isosorbidemononitrate sustained-release tablets). The diltiazem group will be additionally treated with 90\u200amg qd diltiazem sustained-release capsules. The nicorandil group was additionally given 5\u200amg tid nicorandil tablets. Coronary angiography will be performed before treatment, the severity and frequency of chest pain will be evaluated before and after 9\u200amonths of treatment, and homocysteine and von Willebrand factor levels will be measured. Electrocardiography, echocardiography, dynamic electrocardiography, a treadmill exercise test, and CMR will be performed. Sex, age, body mass index, complications, smoking, and family history will also be recorded. The SPSS19.0 statistical software package will be used to analyze the data. The measurements will be expressed as the mean\u200a\u00b1\u200astandard deviation. Measurement data will be compared between the groups using Student's <jats:italic toggle=\"yes\">t<\/jats:italic>-test. A relative number description will be used for the counting data, and the chi-squaretest will be used to compare the groups. A multivariate logistic regression analysis will be performed A <jats:italic toggle=\"yes\">P<\/jats:italic>-value\u200a&lt;\u200a.05 will be considered significant.<\/jats:p>\n            <jats:p>The direct indices (CMR and coronary angiographic TIMI blood flow grade) may improve after adding diltiazem or nicorandil during routine drug treatments (such as aspirin, statins, and nitrates) in PMVA patients, and indirect indices (homocysteine and von Willebrand factor levels) may be reduced.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration:<\/jats:title>\n            <jats:p>Chinese Clinical Trial Registry (http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=41894), No. CHiCTR1900025319, Registered on August 23, 2019; pre initiation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026038","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T15:57:16Z","timestamp":1621958236000},"page":"e26038","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular magnetic resonance image analysis and mechanism study for the changes after treatments for primary microvascular angina pectoris"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-0507","authenticated-orcid":false,"given":"Qi","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De an","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang qian","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"R1-20250504","first-page":"100630","article-title":"International prospective cohort study of microvascular angina-rationale and design","volume":"31","author":"Suda","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R2-20250504","first-page":"196","article-title":"Research progress in treatment of microvascular angina pectoris with traditional Chinese and western medicine","volume":"47","author":"Li","year":"2020","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4070\/kcj.2020.0352","article-title":"Coronary microvascular dysfunction: is it distinct clinical entity or common physiologic pathway?","volume":"50","author":"Ahn","year":"2020","journal-title":"Korean Circ J"},{"key":"R4-20250504","first-page":"988","article-title":"Diagnosis and treatment of coronary microvascular dysfunction","volume":"40","author":"He","year":"2019","journal-title":"Adv Cardiovasc Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"E2880","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"9","author":"Vancheri","year":"2020","journal-title":"J Clin Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1016\/j.jacc.2020.03.051","article-title":"Physiological stratification of patients with angina due to coronary microvascular dysfunction","volume":"75","author":"Rahman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250504","first-page":"957","article-title":"Coronary microvascular dysfunction and microvascular angina","volume":"34","author":"Wang","year":"2018","journal-title":"J Clin Cardiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.CIR.95.2.522","article-title":"Coronary microcirculation in health and disease. Summary of an NHLBI workshop","volume":"95","author":"Chilian","year":"1997","journal-title":"Circulation"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2017.12.046","article-title":"Diagnosis of microvascular angina using cardiac magnetic resonance","volume":"71","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e009019","DOI":"10.1161\/CIRCINTERVENTIONS.120.009019","article-title":"Optimal use of vasodilators for diagnosis of microvascular angina in the cardiac catheterization laboratory","volume":"13","author":"Rahman","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","article-title":"Coronary microvascular dysfunction: mechanisms and functional assessment","volume":"12","author":"Camici","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/hrt.2003.020594","article-title":"Angina pectoris and normal coronary arteries: cardiac syndrome X","volume":"90","author":"Crea","year":"2004","journal-title":"Heart"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.jbiomech.2016.01.044","article-title":"Scaling laws of coronary circulation in health and disease","volume":"49","author":"Huo","year":"2016","journal-title":"J Biomech"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccl.2014.04.006","article-title":"Cardiac Syndrome X: update 2014","volume":"32","author":"Agrawal","year":"2014","journal-title":"Cardiol Clin"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2013.09.055","article-title":"Normal coronary rates for elective angiography in the Veterans Affairs Healthcare System: insights from the VA CART program (veterans affairs clinical assessment reporting and tracking)","volume":"63","author":"Bradley","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cpf.12631","article-title":"Endothelial function in response to exercise in the cold in patients with coronary artery disease","volume":"40","author":"Valtonen","year":"2020","journal-title":"Clin Physiol Funct Imaging"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40256-013-0052-1","article-title":"Management of microvascular angina pectoris","volume":"14","author":"Lanza","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"R21-20250504","first-page":"505","article-title":"Medication and exercise rehabilitation treatment of microvascular angina pectoris","volume":"47","author":"Li","year":"2019","journal-title":"Chin J Clin"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"108","DOI":"10.15420\/icr.2018.15.2","article-title":"\u2018Primary\u2019 microvascular angina: clinical characteristics, pathogenesis and management","volume":"13","author":"Lanza","year":"2018","journal-title":"Interv Cardiol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.2459\/JCM.0000000000000638","article-title":"Microvascular angina: prevalence, pathophysiology and therapy","volume":"19","author":"Villano","year":"2018","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R24-20250504","first-page":"3520","article-title":"The impact of psychiatric disorders with cardiac syndrome X on quality of life: 3\u200amonths prospective study","volume":"7","author":"Altintas","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1093\/eurheartj\/ehy529","article-title":"Systemic microvascular dysfunction in microvascular and vasospastic angina","volume":"39","author":"Ford","year":"2018","journal-title":"Eur Heart J"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1093\/eurheartj\/ehz954","article-title":"Endothelin-1 in coronary microvascular dysfunction: a potential new therapeutic target once again","volume":"41","author":"Corban","year":"2020","journal-title":"Eur Heart J"},{"issue":"(Suppl E)","key":"R27-20250504","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1093\/eurheartj\/suaa075","article-title":"(Epicardial and microvascular) angina or atypical chest pain: differential diagnoses with cardiovascular magnetic resonance","volume":"22","author":"Baggiano","year":"2020","journal-title":"Eur heart J suppl"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2014.11.098","article-title":"Cardiovascular magnetic resonance for the assessment of coronary artery disease","volume":"193","author":"Gotschy","year":"2015","journal-title":"Int J Cardiol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MCA.0000000000000179","article-title":"Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow","volume":"26","author":"Chen","year":"2015","journal-title":"Coron Artery Dis"},{"key":"R30-20250504","first-page":"107","article-title":"Research progress on the mechanism and clinical application of nicorandil in the treatment of coronary microvascular disease","volume":"59","author":"Wen","year":"2019","journal-title":"Shandong Med J"},{"key":"R31-20250504","first-page":"08","article-title":"Effect of long-term application of nicorandil on the clinical efficacy and coronary blood flow of primary stable microangiocardia","volume":"26","author":"Ma","year":"2019","journal-title":"China Modern Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2967\/jnumed.115.162420","article-title":"Prognostic value of myocardial perfusion SPECT after intravenous bolus administration of nicorandil in patients with acute ischemic heart failure","volume":"57","author":"Fukushima","year":"2016","journal-title":"J Nucl Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Task Force","year":"2013","journal-title":"Eur Heart J"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2020.03.052","article-title":"Invasive functional assessment in patients with angina and coronary microvascular dysfunction: a plea for more","volume":"75","author":"Pepine","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:17:40Z","timestamp":1746339460000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":34,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026038","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"2021-04-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}